Trials / Recruiting
RecruitingNCT06778954
Ropivacaine-Poloxamer 407 Gel for Pain Control After Open Gastrectomy
Prospective Randomized Controlled Trial of Ropivacaine-Poloxamer 407 Based Gel Application on Postoperative Pain After Open Gastrectomy
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- Gangnam Severance Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The study evaluates the efficacy of Ropivacaine-Poloxamer 407 hydrogel in reducing postoperative pain following open gastrectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Arm I (Peritoneal application group) | At the end of gastrectomy, during closure of incision, peritoneum and fascia are closed by suture, layer by layer. Skin approximation is doen with skin stapler. Ropivacaine-Poloxamer 407 hydrogel is applied on space between peritoneum and fascia in Arm I. |
| PROCEDURE | Arm II (Subcutaneous injection group) | At the end of gastrectomy, during closure of incision, peritoneum and fascia are closed by suture, layer by layer. Skin approximation is doen with skin stapler. Ropivacaine-Poloxamer 407 hydrogel is injected on subcutaneous area in Arm II. |
Timeline
- Start date
- 2025-01-30
- Primary completion
- 2025-11-01
- Completion
- 2025-12-31
- First posted
- 2025-01-16
- Last updated
- 2025-02-14
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06778954. Inclusion in this directory is not an endorsement.